Eli Lilly & Co. (LLY) Tops Q4 EPS by 39c, Revenues Beat; Offers FY21 EPS/Revenue Guidance
Go back to Eli Lilly & Co. (LLY) Tops Q4 EPS by 39c, Revenues Beat; Offers FY21 EPS/Revenue Guidance| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1149.44 +33.74 (3.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1115.70 | 52 Week High | $88.16 | |||
| Open | $1142.20 | 52 Week Low | $67.88 | |||
| Day High | $1153.95 | P/E | 266.07 | |||
| Day Low | $1130.50 | EPS | $4.32 | |||
| Volume | 915,569 | |||||

